The Arg16Gly polymorphism of human β2-adrenoreceptor is associated with type 2 diabetes in Taiwanese people

Clinical Endocrinology

Volumn 57, Issue 5, 2002, Pages 685-690

  Chang, Tien Jyun ^a,b   Tsai, Ming Han ^b   Jiang, Yi Der ^b   Lee, Borheng ^c   Lee, Kuan Ching ^b   Lin, Jin Yu ^c   Chiu, Ken C ^d   Tai, Tong Yuan ^b   Chuang, Lee Ming ^b  

^a En Chu Kung Hospital   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c Yuan Shan Research Institute   (Taiwan)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR;

ADULT; AGE; ARTICLE; BODY MASS; CASE CONTROL STUDY; CODON; CONTROLLED STUDY; FEMALE; GENDER; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE TOLERANCE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; TAIWAN;

ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-2; TAIWAN;

EID: 0036425967     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2002.01661.x     Document Type: Article

References (27)

1. Allison, D.B., Fontaine, K.R., Manson, J.E., Stevens, J. & Van Itallie, T.B. (1999) Annual deaths attributable to obesity in the United States. Journal of the American Medical Association, 284, 1530-1538.
2. Arkwright, P.D., Laurie, S., Super, M., Pravica, V., Schwarz, M.J., Webb, A.K. & Hutchinson, I.V. (2000) TGF-β1 genotype and accelerated decline in lung function of patients with cystic fibrosis. Thorax, 55, 459-462.
3. Barbe, P., Millet, L., Galitzki, J., Lafonatan, M. & Berlan, M. (1996) In situ assessment of the role of β1-, β2-, and β3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue. British Journal of Pharmacology, 117, 907-913.
4. Bengtsson, K., Orho-Melander, M., Melander, O., Lindblad, U., Ranstam, J., Råstam, L. & Groop, L. (2001) β2-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. Hypertension, 37, 1303-1308.
5. Calle, E.E., Thun, M.J., Petrelli, J.M., Rodriguez, C. & Heath, C.W. Jr (1999) Body mass index and motrality in a prospective cohort of US adults. New England Journal of Medicine, 341, 1097-1105.
6. Carlsson, M., Orho-Melander, M., Hedenbro, J. & Groop, L.C. (2001) Common variants in the β2-(Gln27Glu) and β3-(Tryp64Arg) -adrenoceptor genes are associated with elevated serum NEFA concentrations and type II diabetes. Diabetologia, 44, 629-636.
7. Clément, K., Vaisse, C., Manning, B.S., Basdevant, A., Guy-Grand, B., Ruiz, J., Silver, K.D., Shuldiner, A.R., Froguel, P. & Strosberg, A.D. (1995) Genetic variation in the β3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. New England Journal of Medicine, 333, 352-354.
8. Comuzzie, A.G. & Allison, D.B. (1998) The search for human obesity genes. Science, 280, 1374-1377.
9. Enocksson, S., Shimizu, M., Lonnqvist, F., Nordenstrom, J. & Arner, P. (1995) Demonstration of an in vivo junction β3-adrenoceptor in man. Journal of Clinical Investigation, 95, 2239-2245.
10. Gagnon, J., Mauriege, P., Roy, S., Sjostrom, D., Chagnon, Y.C., Dionne, F.T., Oppert, J.M., Perusse, L., Sjostrom, L. & Bouchard, C. (1996) The Trp64Arg mutation of the β3 adrenergic receptor gene has no effect on obesity phenotypes in the Quebec Family Study and Swedish Obese Subjects cohorts. Journal of Clinical Investigation, 98, 2086-2093.
11. Green, S.A., Turki, J., Innis, M. & Liggett, S.B. (1994) Amino-terminal polymorphisms of the human β2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry, 33, 9414-9419.
12. Harris, M.I., Eastman, R.C., Cowie, C.C., Flegal, K.M. & Eberhardt, M.S. (1997) Comparison of diagnostic categories in the US population according to the 1997 American Diabetes Association and 1980-85 World Health Organization diagnostic criteria. Diabetes Care, 20, 1859-1862.
13. Hill, J.O. & Peters, J.C. (1998) Environmental contributions to the obesity epidemic. Science, 280, 1371-1374.
14. Ishiyama-Shigemoto, S., Yamada, K., Yuan, X., Ichikawa, F. & Nonaka, K. (1999) Association of polymorphisms in the β2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia, 42, 98-101.
15. Kadowaki, H., Yasuda, K., Iwamoto, K., Otabe, S., Shimokawa, K., Silver, K., Walston, J., Yoshinaga, H., Kosaka, K. & Yamada, N. (1995) A mutation in the β3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochemical and Biophysical Research Communications, 215, 555-560.
16. Kato, N., Sugiyama, T., Morita, H., Kurihara, H., Sato, T., Yamori, Y. & Yazaki, Y. (2001) Association analysis of β2-adrenergic receptor polymorphisms with hypertension in Japanese. Hypertension, 37, 286-292.
17. Kurabayashi, T., Carey, D.G.P. & Morrison, N.A. (1996) The β3-adrenergic receptor gene Trp64Arg mutation is overrepresented in obese women: Effects on weight, BMI, abdominal fat, blood pressure, and reproductive history in an elderly Australian population. Diabetes, 45, 1358-1363.
18. Lafontan, M. & Berlan, M. (1993) Fat cell adrenergic receptor and the control of white and brown fat cell function. Journal of Lipid Research, 34, 1057-1091.
19. Large, V., Hellstrom, L., Reynisdottir, S., Lonnqvist, F., Eriksson, P., Lannfelt, L. & Arner, P. (1997) Human β2 adrenoceptor gene polymorphisms are highly frequent in obesity and associated with altered adipocyte β2 adrenoceptor function. Journal of Clinical Investigation, 100, 3005-3013.
20. Lönnqvist, F., Thöme, A., Nilsell, K., Hoffstedt, J. & Arner, P. (1995) A pathogenic role of visceral fat β3-adrenoceptors in obesity. The Journal of Clinical Investigation, 95, 1109-1116.
21. Mokdad, A.H., Serdula, M.K., Dietz, W.H., Bowman, B.A., Marks, J.S. & Koplan, J.P. (1999) The spread of the obesity epidemic in the United States. Journal of the American Medical Association, 282, 1519-1522.
22. Must, A., Spandano, J., Coakley, E.H., Field, A.E., Colditz, G. & Dietz, W.H. (1999) The disease burden associated with overweight and obesity. Journal of the American Medical Association, 282, 1523-1529.
23. Permutt, M.A., Chiu, K.C. & Tanizawa, Y. (1992) Glucokinase and NIDDM. A candidate gene that paid off. Diabetes, 41, 1367-1372.
24. Reihsaus, E., Innis, M., MacIntyre, N. & Liggette, S.B. (1993) Mutations in the gene encoding for the β2-adrenergic receptor in normal and asthmatic subjects. American Journal of Respiratory Cell and Molecular Biology, 8, 334-339.
25. Reynisdottir, S., Langin, D., Carlström, K., Holm, C., Rössner, S. & Arner, P. (1995) Effects of weight reduction on the regulation of lipolysis in adipocytes of women with upper-body obesity. Clinical Science, 89, 421-429.
26. Sham, P.C. & Curtis, D. (1995) Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Annals of Human Genetics, 59, 97-105.
27. Yuan, X., Yamada, K., Koyama, K., Ichikawa, F., Ishiyama, S., Koyanagi, A., Koyama, W. & Nonaka, K. (1997) β3-adrenergic receptor gene polymorphism is not a major genetic determinant of obesity and diabetes in Japanese general population. Diabetes Research and Clinical Practice, 37, 1-7.